Engineers Gate Manager LP Raises Stake in Agilent Technologies, Inc. $A

Engineers Gate Manager LP boosted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 10.1% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 126,957 shares of the medical research company’s stock after acquiring an additional 11,668 shares during the period. Engineers Gate Manager LP’s holdings in Agilent Technologies were worth $16,864,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of A. Cidel Asset Management Inc. acquired a new stake in shares of Agilent Technologies during the second quarter worth about $226,000. Integrated Wealth Concepts LLC grew its holdings in shares of Agilent Technologies by 0.8% during the second quarter. Integrated Wealth Concepts LLC now owns 11,555 shares of the medical research company’s stock worth $1,535,000 after buying an additional 88 shares during the last quarter. NewEdge Advisors LLC grew its holdings in shares of Agilent Technologies by 58.5% during the second quarter. NewEdge Advisors LLC now owns 28,456 shares of the medical research company’s stock worth $3,780,000 after buying an additional 10,505 shares during the last quarter. IFP Advisors Inc increased its position in Agilent Technologies by 14.3% in the 2nd quarter. IFP Advisors Inc now owns 2,080 shares of the medical research company’s stock valued at $276,000 after acquiring an additional 261 shares during the period. Finally, Baird Financial Group Inc. raised its stake in Agilent Technologies by 53.8% during the 2nd quarter. Baird Financial Group Inc. now owns 91,342 shares of the medical research company’s stock valued at $12,133,000 after acquiring an additional 31,940 shares during the last quarter.

Agilent Technologies Price Performance

Shares of NYSE A opened at $144.79 on Thursday. The stock has a market cap of $40.82 billion, a price-to-earnings ratio of 28.50, a PEG ratio of 2.24 and a beta of 1.24. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $163.75. The company’s 50-day moving average price is $143.14 and its 200 day moving average price is $128.35. The company has a current ratio of 2.05, a quick ratio of 1.56 and a debt-to-equity ratio of 0.50.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The firm had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. During the same period last year, the firm posted $1.37 EPS. The firm’s revenue for the quarter was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, research analysts forecast that Agilent Technologies, Inc. will post 6.2 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A has been the topic of several analyst reports. Wells Fargo & Company lowered their target price on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Thursday, May 28th. JPMorgan Chase & Co. increased their price target on Agilent Technologies from $180.00 to $190.00 and gave the stock an “overweight” rating in a report on Thursday, August 27th. Barclays lifted their price objective on shares of Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a research report on Thursday, August 27th. Royal Bank Of Canada boosted their price objective on shares of Agilent Technologies from $155.00 to $185.00 and gave the company an “outperform” rating in a research note on Thursday, August 27th. Finally, Stifel Nicolaus raised their target price on shares of Agilent Technologies from $170.00 to $180.00 and gave the stock a “buy” rating in a research note on Thursday, August 27th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $170.33.

Insider Activity

In related news, Director Mikael Dolsten sold 634 shares of Agilent Technologies stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $151.38, for a total transaction of $95,974.92. Following the completion of the transaction, the director directly owned 4,924 shares in the company, valued at $745,395.12. The trade was a 11.41% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

About Agilent Technologies

Agilent Technologies, Inc is a global provider of analytical instruments, laboratory software, consumables and services used by organizations in the life sciences, diagnostics, pharmaceutical, chemical, environmental and food industries. Its solutions help customers analyze the composition and quality of substances, develop and manufacture products, and conduct research and testing.

The company’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic analysis equipment, automated electrophoresis systems, laboratory informatics software, columns and other consumables.